Last reviewed · How we verify
albiglutide uptitration
At a glance
| Generic name | albiglutide uptitration |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | Phase 3 |
Approved indications
Common side effects
- Nasopharyngitis
- Hypoglycaemia
- Constipation
- Diabetic retinopathy
- Contusion
- Gastroenteritis
- Bronchitis
- Pharyngitis
- Back pain
- Diarrhoea
Key clinical trials
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects (PHASE4)
- A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus (PHASE3)
- Safety and Efficacy Study of Albiglutide in Type 2 Diabetes (PHASE3)
- Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |